全文获取类型
收费全文 | 3245篇 |
免费 | 163篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 115篇 |
妇产科学 | 50篇 |
基础医学 | 432篇 |
口腔科学 | 50篇 |
临床医学 | 239篇 |
内科学 | 552篇 |
皮肤病学 | 51篇 |
神经病学 | 297篇 |
特种医学 | 83篇 |
外科学 | 469篇 |
综合类 | 11篇 |
预防医学 | 512篇 |
眼科学 | 99篇 |
药学 | 182篇 |
中国医学 | 9篇 |
肿瘤学 | 244篇 |
出版年
2023年 | 20篇 |
2022年 | 23篇 |
2021年 | 42篇 |
2020年 | 31篇 |
2019年 | 50篇 |
2018年 | 50篇 |
2017年 | 35篇 |
2016年 | 53篇 |
2015年 | 49篇 |
2014年 | 68篇 |
2013年 | 93篇 |
2012年 | 167篇 |
2011年 | 186篇 |
2010年 | 87篇 |
2009年 | 77篇 |
2008年 | 188篇 |
2007年 | 187篇 |
2006年 | 169篇 |
2005年 | 169篇 |
2004年 | 128篇 |
2003年 | 126篇 |
2002年 | 125篇 |
2001年 | 107篇 |
2000年 | 105篇 |
1999年 | 86篇 |
1998年 | 35篇 |
1997年 | 29篇 |
1996年 | 25篇 |
1995年 | 29篇 |
1994年 | 22篇 |
1992年 | 59篇 |
1991年 | 48篇 |
1990年 | 76篇 |
1989年 | 62篇 |
1988年 | 47篇 |
1987年 | 43篇 |
1986年 | 66篇 |
1985年 | 41篇 |
1984年 | 29篇 |
1983年 | 35篇 |
1979年 | 34篇 |
1978年 | 20篇 |
1975年 | 19篇 |
1974年 | 20篇 |
1973年 | 19篇 |
1972年 | 20篇 |
1971年 | 17篇 |
1970年 | 17篇 |
1969年 | 27篇 |
1967年 | 18篇 |
排序方式: 共有3432条查询结果,搜索用时 15 毫秒
51.
The authors of this study report an extraordinary case which is rather rare even in the medical literature. The patient who suffered from recurrence pancreatitis was taken to hospital in septic condition. In the background of the septic condition lied the acut exacerbate of pancreatitis. Besides, in the right side of the thoracic cavity as well as in the peritoneal cavity fistulas of pancreal tail's pseudocyst was found. It was proved by clinical, laboratory and imaging procedure examinations. During the operation external drainage of the pseudocyst was carried out. After several thoracocentesis chylothorax was developed which was cured by permanent chest tube drainage. 相似文献
52.
Florence Lefranc Tatjana Mijatovic Véronique Mathieu Sandrine Rorive Christine Decaestecker Olivier Debeir Jacques Brotchi Philippe Van Ham Isabelle Salmon Robert Kiss 《Clinical cancer research》2004,10(24):8250-8265
PURPOSE: This study aims to investigate the role of gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo. EXPERIMENTAL DESIGN: The influences of G17 and G17 receptor antagonists were characterized in vitro in terms of angiogenesis on human umbilical vein endothelial cell (HUVEC) tubulogenesis processes on Matrigel and in vivo with respect to U373 orthotopic glioma xenografts. The influence of phosphatidylinositol 3'-kinase, protein kinase C, and nuclear factor-kappaB inhibitors was characterized in vitro on G17-mediated HUVEC tubulogenesis. G17-mediated release of interleukin (IL)-8 from HUVECs and G17-induced modifications in nuclear factor-kappaB DNA binding activity were characterized by means of specific enzyme-linked immunosorbent assays. The influence of G17 on E- and P-selectin expression was determined by means of computer-assisted microscopy, whereas the influence of E- and P-selectin on HUVEC migration was approached by means of antisense oligonucleotides. The chemotactic influence of G17 and IL-8 on HUVEC migration was characterized by means of computer-assisted videomicroscopy with Dunn chambers. RESULTS: Messenger RNAs for cholecystokinin (CCK)A, CCKB, and CCKC receptors were present in HUVECs and microvessels dissected from a human glioblastoma. Whereas G17 significantly increased the levels of angiogenesis in vivo in the U373 experimental glioma model and in vitro in the HUVECs, the CCKB receptor antagonist L365,260 significantly counteracted the G17-mediated proangiogenic effects. G17 chemoattracted HUVECs, whereas IL-8 failed to do so. IL-8 receptor alpha (CXCR1) and IL-8 receptor beta (CXCR2) mRNAs were not detected in these endothelial cells. Gastrin significantly (but only transiently) decreased the level of expression of E-selectin, but not P-selectin, whereas IL-8 increased the expression of E-selectin. Specific antisense oligonucleotides against E- and P-selectin significantly decreased HUVEC tubulogenesis processes in vitro on Matrigel. CONCLUSIONS: The present study shows that gastrin has marked proangiogenic effects in vivo on experimental gliomas and in vitro on HUVECs. This effect depends in part on the level of E-selectin activation, but not on IL-8 expression/release by HUVECs. 相似文献
53.
Cook JL Khan KM Kiss ZS Griffiths L 《Scandinavian journal of medicine & science in sports》2000,10(4):216-220
Anterior knee pain is a common presenting complaint amongst adolescent athletes. We hypothesised that patellar tendinopathy may occur at a younger age than is generally recognised. Thus, we studied the patellar tendons in 134 elite 14- to 18-year-old female (n=64) and male (n=70) basketball players and 29 control swimmers (17 female, 12 male) clinically and with ultrasonography. We found that of 268 tendons, 19 (7%) had current patellar tendinopathy on clinical grounds (11% in males, 2% in females). Twenty-six percent of the basketball players' patellar tendons contained an ultrasonographic hypoechoic region. Ultrasonographic abnormality was more prevalent in the oldest tertile of players (17-18 years) than the youngest tertile (14-15.9 years). Of tendons categorised clinically as 'Never patellar tendinopathy', 22% had an ultrasonographic hypoechoic region nevertheless. This study indicates that patellar tendinopathy can occur in 14- to 18-year-old basketball players. Ultrasonographic tendon abnormality is 3 times as common as clinical symptoms. 相似文献
54.
Hoyaux D Decaestecker C Heizmann CW Vogl T Schäfer BW Salmon I Kiss R Pochet R 《Brain research》2000,867(1-2):280-288
Corpora amylacea (C.A.) also named polyglucosan bodies (P.B.) are one of the hallmarks of normal brain aging. Although their functions are not yet clear, C.A. increase in number in patients suffering from neurodegenerative diseases. C.A. contain 88% of hexoses and 4% of proteins. Most of the proteins in C.A. are aging or stress proteins such as heat shock proteins, ubiquitinated proteins and advanced glycation end products which are also proinflammatory products. Stimulated by the potential role played by some S100 proteins in the inflammatory process which may be triggered in C.A., we investigated, by immunohistochemistry, the presence of different S100 proteins (S100A1, S100A2, S100A3, S100A4, S100A5, S100A6, S100A8, S100A9, S100A12 and S100B) in C.A. from normal human brain. Among the ten S100 proteins analyzed, nine (S100A) were detected in C.A. Three S100 proteins (S100A8, S100A9, S100A12) which are highly expressed in activated macrophages and used as inflammatory markers were detected in C.A. S100A8 was, in addition, found in thick neuronal processes from the pons. One (S100B) could not be found in C.A. although it was highly expressed in astrocytes. In C.A., the staining intensity was estimated by computer-assisted microscopy and gave the following order: S100A1 congruent withS100A8 congruent with S100A9>S100A5> or =S100A4>S100A12>S100A6> S100A2=S100A3. The potential inflammatory role played by S100 proteins in C.A. is discussed. 相似文献
55.
56.
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. 总被引:14,自引:0,他引:14
PURPOSE: The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult. METHODS: The present review surveys the molecular mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addition to relationships between glioma cell migration and resistance to apoptosis in terms of the molecular signaling pathways. RESULTS: Clinical and experimental data demonstrate that glioma cell migration is a complex combination of multiple molecular processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton. Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern PI3K, Akt, mTOR, NF-kappaB, and autophagy (programmed cell death type II). CONCLUSION: A number of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults. However, these pathways are not all constitutively activated at the same time in any one glioma. Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the molecular profiling of their tumors before undergoing any treatment to combat their migratory glioma cells. Specific antimigratory compounds should be added to conventional radio- and/or chemotherapy. 相似文献
57.
58.
59.
Ursula Schmidt-Erfurth Christopher Kiss Stefan Sacu 《Progress in retinal and eye research》2009,28(2):145-154
The clinical benefits of verteporfin therapy have been documented in a wide variety of patients with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD), and there is encouraging evidence of improved outcomes when this angioocclusive modality is combined with antiangiogenic agents. Although the clinical benefits of verteporfin mono- and combination therapy are well established, there has been concern that treatment with verteporfin results in hypoperfusion in the treated area and that concomitant use of antiangiogenic agents could prolong this effect. However, despite well-documented occurrences of hypoperfusion on fluorescein and indocyanine green angiography, there is little evidence of associations with functional impairment or other adverse effects. It has also been suggested that hypoperfusion might actually help to reduce recanalization of CNV and permit neuronal recovery by decreasing exposure to oxygen and oxidative radicals. The reduced need for frequent retreatments clearly has a major appeal due to the lower costs associated with fewer interventions and reduced burden of clinical monitoring and diagnostic reevaluations. Ongoing evaluation in randomized clinical trials will provide further clarification on the effect of verteporfin plus ranibizumab compared with ranibizumab monotherapy in terms of visual acuity, anatomical outcomes, treatment frequency, and health economics. The results of these large-scale clinical trials will provide a strong basis for determining the benefits and risks of combination therapy. 相似文献